Pirmitegravir
Pirmitegravir (STP0404) is a potent and selective inhibitor of allosteric integrase (ALLINI) targeting the LEDGF/p75 binding site. Pirmitegravir inhibits PBMC. Pirmitegravir inhibits PBMC.Pirmitegravir has significant antiviral activity and may be useful in the study of HIV virus infection.
Product Specifications
CAS Number
2245231-10-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
495.01
Molecular Formula
C27H31ClN4O3
Notes
Research use only, not for human use.
Receptor
HIV Protease
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
